US-based healthcare products company Perrigo Co. (PRGO) has agreed to acquire Irish biotechnology firm Elan Corp. Plc. (ELN) in a cash and stock transaction valued at about $8.6 billion. Elan, which recently refused to be acquired by …
Mr. Donal O'Connor is Independent Director of the Company. He has been a director of Perrigo since November 2014 and was previously a director of Elan Corporation, plc from May 2008 until Perrigo’s acquisition of Elan in December 2013. …
We screened the Jefferies list of specialty pharmaceutical companies that had the largest ... and Perrigo Co. PLC (NYSE: PRGO) were the focal points of the report. We have shown each of the “why” rationales on these. Also included are …
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Perrigo (PRGO) today after it ... as long as the stock closes above $95 at expiration.
Perrigo Company plc PRGO reported first-quarter 2017 earnings of $1.05 per ... underperformed the Zacks classified Medical Products industry so far this year. The stock has lost 18.3% compared to the broader industry’s gain of 16%. …
This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from …
Find out more about Jazz Pharmaceuticals including full access to the free equity report at: www.RDInvesting.com/JAZZ …